This federal contract award to Amerisourcebergen Drug Corp is a $1,800.00 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for GLATOPA 40 MG/ML syringes. The contract has an ultimate completion date of September 18, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $32,419.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on March 4, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award, with a ceiling value of $6,173.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. This...
This federal contract award is for the delivery of Glatopa 40 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,533.26 and was awarded on February 17, 2022, with a completion date of February 18, 2022. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glatopa 20 mg/mL syringes. The contract is a delivery order valued at $4,281.50 with a completion date of June 9, 2022. The contract is a firm fixed-price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., another for-profit pharmaceutical distribution...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $5,780.28 and a period of performance ending on October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Glatiramer 40 mg/ml syringes. The $1,129.45 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is for the delivery of glatiramer 40 mg/ml syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,158.51 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGE, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of glatiramer 40 mg/ml syringes. The contract has a potential value of $6,212.78 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) it holds with DLA valued up to...